China Pharma Holdings (CPHI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 268 | 625 | 413 | 627 | 719 |
| Marketable Securities | 27 | N/A | N/A | 19 | 27 |
| Receivables | 286 | 317 | 368 | 262 | 380 |
| Inventories | 1,650 | 1,679 | 1,979 | 2,266 | 2,499 |
| Other current assets | 24 | 5 | 9 | 15 | 0 |
| TOTAL | $2,329 | $2,701 | $2,851 | $3,270 | $3,739 |
| Non-Current Assets | |||||
| PPE Net | 4,503 | 4,626 | 4,777 | 4,883 | 5,306 |
| Intangibles | 8,775 | 6,440 | 6,570 | 6,695 | 4,362 |
| Other Non-Current Assets | 198 | 0 | 19 | 38 | 59 |
| TOTAL | $13,475 | $11,066 | $11,366 | $11,617 | $9,727 |
| Total Assets | $15,805 | $13,767 | $14,217 | $14,888 | $13,466 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,956 | 699 | 940 | 1,016 | 1,042 |
| Accounts payable and accrued liabilities | 4,305 | 4,283 | 3,852 | 3,553 | 3,235 |
| Accrued Expenses | 170 | 191 | 195 | 247 | 83 |
| Other current liabilities | 121 | 78 | 114 | 162 | 25 |
| TOTAL | $6,623 | $5,251 | $5,122 | $5,017 | $4,760 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 1,320 | 1,393 | 1,391 | 1,427 |
| Other Non-Current Liabilities | 128 | 0 | 0 | 0 | 0 |
| TOTAL | $868 | $2,054 | $2,125 | $2,122 | $2,177 |
| Total Liabilities | $7,491 | $7,305 | $7,247 | $7,140 | $6,937 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,022 | 3,262 | 3,262 | 3,262 | 1,925 |
| Common Shares | 5 | 3 | 3 | 3 | 18 |
| Retained earnings | -45,992 | -45,341 | -44,812 | -44,027 | -42,802 |
| Other shareholders' equity | 11,225 | 11,167 | 11,147 | 11,140 | 11,523 |
| TOTAL | $8,314 | $6,462 | $6,970 | $7,748 | $6,528 |
| Total Liabilities And Equity | $15,805 | $13,767 | $14,217 | $14,888 | $13,466 |